How many other drugs would they have which could simultaneously:
a) extend their patent life by up to 20 years,
b) expand their patient population to include people with a history of cardiac problems,
c) increase the effectiveness of Kyprolis, and,
d) result in less severe side-effects in patients receiving Kyprolis.
I would expect the list is not that long.
How many other drugs would they have which could...
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.070(4.17%) |
Mkt cap ! $276.0M | |||
| Open | High | Low | Value | Volume |
| $1.67 | $1.67 | $1.61 | $104.9K | 65.01K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1233 | $1.62 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.63 | 104 | 5 |
View Market Depth
| Last trade - 10.48am 09/09/2024 (20 minute delay) ? |
| RAC (ASX) Chart |